AXIM BIOTECHNOLOGIES, INC. (AXIM) Operating income 2015–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) annual operating income history from SEC filings — each fiscal year as reported.
-$2.8MFY2023 · since FY2015: -$10.0M → -$2.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$2.8M | -287.1% |
| FY2022 | -$710,634 | +94.9% |
| FY2021 | -$14.0M | -182.4% |
| FY2020 | -$4.9M | -59.2% |
| FY2019 | -$3.1M | +38.3% |
| FY2018 | -$5.0M | -59.9% |
| FY2017 | -$3.1M | +16.2% |
| FY2016 | -$3.8M | +62.6% |
| FY2015 | -$10.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AXIM financial trends
AXIM RevenueAXIM Net incomeAXIM Net marginAXIM Gross profitAXIM Gross marginAXIM Operating marginAXIM Operating cash flowAXIM Free cash flowAXIM Capital expendituresAXIM Return on equityAXIM Stock buybacksAXIM Dividends paidAXIM Total assetsAXIM Total liabilitiesAXIM Shareholders’ equityAXIM overview →